ClinicalTrials.gg
RecruitingNCT07432789Valid-ABLEUpdated Apr 17, 2026

Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performance of Children With Cerebral Palsy

An interventional study of Assessment of functional abilities and Children's self-questionnaires in Cerebral Palsy, sponsored by Centre Hospitalier Universitaire Dijon. Recruiting at 1 site in France. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-17.

Sponsored by Centre Hospitalier Universitaire Dijon · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
6 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Cerebral Palsy with a site in France — 29 open to participants now, 30 under way, none of them phase 3. Cerebral Palsy · France.

Planned enrollment
20th of 59
60 · median 36
Started
2026
with 6 others
No phase
48 of 91
20 open now
Primary completion
2028-11
later than 20 of 29 live
Registered
85th of 91
by date
Lead sponsor
4 of 91
Centre Hospitalier Universitaire Dijon

Among the 91 studies in Cerebral Palsy with a site in France, this one is the 20th largest by planned enrollment of the 59 interventional ones that give a count, is one of 7 that started in 2026, is one of 48 with no phase, reaches primary completion later than 20 of the 29 other live ones, and was the 85th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

29 of the 91 studies in Cerebral Palsy with a site in France are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Cerebral Palsy with a site in France, or all of them as a file.
02

Study summary

Cerebral palsy is a common neurological disorder that is the leading cause of motor disability in children. It causes significant motor impairments, affecting various aspects such as fine and gross motor skills, as well as locomotion, which has a major impact on the quality of life of affected children. It is therefore essential to characterize these functional impairments in order to guide clinical decisions and maximize the motor function of affected children.

Currently, the assessment of motor function is based on physical examinations and functional scales, such as the Gross Motor Function Classification System, which is specifically designed to assess children with CP. However, movement analysis using optoelectronic systems is considered the gold standard for this assessment, even though these systems have notable limitations (expensive installation, time-consuming use, and use only in a clinical environment, making it difficult to assess motor skills in children's everyday lives). In order to establish a comprehensive and personalized functional diagnosis, it is crucial to evaluate other fundamental motor tasks such as running, jumping, object control, and balance tasks. Recently, innovative markerless motion analysis technologies have been developed that allow analysis using smartphones or tablets outside of healthcare facilities. Therefore, developing an application dedicated to motion analysis for children with cerebral palsy that is easy to access and can be used frequently could yield many significant benefits.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Common to both groups:

  • Obtaining free and from the child and at least one parent
  • Children of all genders aged 6 to 18
  • Children affiliated with or beneficiaries of a social security system

For the Cerebral Palsy group:

  • Medical diagnosis of CP according to the SCPE (Surveillance of Cerebral Palsy in Europe) definition;
  • Unilateral and bilateral impairment;
  • Gross Motor Function Classification System (GMFCS) = I to III;
  • No major cognitive or visual impairments that limit the performance of motor tasks

For the control group:

- Children free from any disease

Other volunteers included in the protocol (qualitative analysis only (parents and clinicians)):

  • Parent(s) of children with CP included in this study;
  • Healthcare professionals and researchers involved in monitoring children with CP and/or evaluating the research application within the framework of this study

Exclusion criteria

Exclusion Criteria:

Common to both groups:

  • Participants or parent(s) of participants who do not speak French
  • Children subject to legal protection measures
  • Pregnant or breastfeeding participants

For the Cerebral Palsy group:

  • Presence of a cause of neuro-orthopedic disorders other than CP
  • Limiting pain
  • Surgical procedures performed less than 6 months prior to inclusion in the study
  • Any other functional medical intervention that took place 3 months prior to inclusion in the study (e.g., botulinum toxin injections, plaster casts, etc.)
  • Medical or surgical interventions planned between visit 1 and visit 2
  • Children with a condition other than cerebral palsy that affects their walking ability
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Children with a medical diagnosis of cerebral palsy as defined by SCPE

    Other: Assessment of functional abilities · Other: Children's self-questionnaires · Other: Parent self-assessment questionnaires · Other: Semi-structured interview

  • Active comparator
    Healthy volunteers

    Other: Assessment of functional abilities

Interventions

  • OtherAssessment of functional abilities

    Gold standard

  • OtherChildren's self-questionnaires

    ABILOCO-Kids

  • OtherParent self-assessment questionnaires

    GOAL

  • OtherSemi-structured interview

    Interview

  • OtherAssessment of functional abilities

    Application

06

What researchers measure

Primary outcomes

  1. Angle (in degrees) of knee flexion in sagittal view during a two-foot vertical jump using digital motion analysis software

    We will measure the left and right knees, which will be classified as either the most affected lower limb or the least affected lower limb in the PC group.

    Time frame: Up to 8 months

  2. Angle (in degrees) of knee flexion in sagittal view during a two-foot vertical jump using the Gold Standard system (Motion Capture System).

    We will measure the left and right knees, which will be classified as either the most affected lower limb or the least affected lower limb in the PC group.

    Time frame: Up to 8 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Nov 2028, 31 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 31 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Feb 25, 2026
StartActual
Mar 18, 2026
Primary completionEst.
Nov 16, 2028
CompletionEst.
Nov 16, 2028
Last update
Apr 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07432789
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Mar 18, 2026
Primary completion
Nov 16, 2028 (estimated)
Completion
Nov 16, 2028 (estimated)
Last update
Apr 17, 2026

Study contacts

Paul ORNETTI
Contact
paul.ornetti@chu-dijon.fr
03.80.29.38.72 ext. +33

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion